Novartis has entered into an agreement to sell 53.3 million (approximately 33%) Roche bearer shares in a bilateral transaction to Roche for a consideration of USD 20.7 billion. Novartis had acquired the stake between 2001 and 2003 for approximately USD 5
Tags :Rudolf Tschäni
Homburger’s arbitration team was led by partner Mariella Orelli (pictured left). Lenz & Staehelin with Rudolf Tschäni (pictured right) and Harold Frey advised and acted as second counsel
